T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.64% |
| 2 | Consumer Discretionary | 13.46% |
| 3 | Financials | 12.79% |
| 4 | Industrials | 12.13% |
| 5 | Technology | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EMC
676
DELISTED
EMC CORPORATION
EMC
| $88.7M | 0.02% |
3,369,211
-352,720
| -9% | -$9.31M |
|
|
FRAN
677
DELISTED
Francesca's Holdings Corporation
FRAN
| $88.7M | 0.02% |
501,193
+62,241
| +14% | +$12M |
|
|
VOLC
678
DELISTED
VOLCANO CORPORATION COM STK
VOLC
| $88.6M | 0.02% |
5,029,410
-20,270
| -0.4% | -$369K |
|
679
Alexandria Real Estate Equities
ARE
$8.33B
| $88.6M | 0.02% |
1,140,611
-36,419
| -3% | -$2.73M |
|
|
PCH
680
DELISTED
PotlatchDeltic
PCH
| $88M | 0.02% |
2,125,300
+73,940
| +4% | +$2.9M |
|
|
ININ
681
DELISTED
Interactive Intelligence Group, inc.
ININ
| $86.7M | 0.02% |
1,545,044
+486,340
| +46% | +$27.8M |
|
682
iShares Russell 2000 Value ETF
IWN
$14.7B
| $85.1M | 0.02% |
823,850
-1,200
| -0.1% | -$119K |
|
683
Terreno Realty
TRNO
$7.5B
| $85M | 0.02% |
4,399,628
+903,479
| +26% | +$17M |
|
684
RB Global
RBA
$16B
| $84.3M | 0.02% |
3,421,340
-1,057,070
| -24% | -$25.2M |
|
685
Centene
CNC
$32.6B
| $84.1M | 0.02% |
4,450,640
+1,021,640
| +30% | +$17.6M |
|
686
West Pharmaceutical
WST
$24.4B
| $84.1M | 0.02% |
1,993,687
+10,732
| +0.5% | +$460K |
|
687
Rayonier
RYN
$6.54B
| $83.9M | 0.02% |
2,602,046
-553,157
| -18% | -$17.3M |
|
688
TETRA Technologies
TTI
$1.25B
| $83.9M | 0.02% |
7,123,870
+77,150
| +1% | +$927K |
|
|
BV
689
DELISTED
Bazaarvoice, Inc.
BV
| $83.5M | 0.02% |
10,584,119
-764,191
| -7% | -$5.34M |
|
690
Monster Beverage
MNST
$91.4B
| $83.1M | 0.02% |
14,036,508
-4,888,932
| -26% | -$27.9M |
|
691
Wheaton Precious Metals
WPM
$59.9B
| $82.8M | 0.02% |
3,149,378
+1,845,376
| +142% | +$41.3M |
|
|
BNY
692
Bank of New York Mellon
BNY
$110B
| $82.3M | 0.02% |
2,196,874
+29,590
| +1% | +$1.02M |
|
693
Post Holdings
POST
$3.65B
| $82.3M | 0.02% |
2,470,200
+946,944
| +62% | +$31.7M |
|
694
Brinker International
EAT
$10.2B
| $82.3M | 0.02% |
1,691,674
+21,920
| +1% | +$1.1M |
|
|
IRBT
695
DELISTED
iRobot
IRBT
| $82M | 0.02% |
2,002,484
+697,100
| +53% | +$25.2M |
|
696
Navient
NAVI
$867M
| $81.7M | 0.02% |
+4,612,468
| New | +$76.3M |
|
697
Angi Inc
ANGI
$196M
| $81.6M | 0.02% |
683,708
+146,355
| +27% | +$16.7M |
|
|
CIVI
698
DELISTED
Civitas Resources
CIVI
| $81.4M | 0.02% |
12,754
-9,841
| -44% | -$55.7M |
|
699
Worthington Enterprises
WOR
$2.85B
| $81.2M | 0.02% |
3,059,060
+1,982,599
| +184% | +$48M |
|
|
YHOO
700
DELISTED
Yahoo Inc
YHOO
| $80.7M | 0.02% |
2,297,956
+307,119
| +15% | +$10.7M |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.